PHM 📈 PulteGroup - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7458671010
PHM: Houses, Apartments, Mortgage Loans, Title Insurance, Home Financing
PulteGroup, Inc. operates as a prominent homebuilding company in the United States, with a business model that encompasses land acquisition, development, and construction of residential properties. The company's primary focus is on building a diverse range of housing units, including single-family detached homes, townhomes, condominiums, and duplexes, which cater to various consumer preferences and needs. Through its subsidiaries, PulteGroup manages the entire process, from land acquisition to construction, ensuring that the final product meets the company's quality and design standards.
The company's product offerings are marketed under several brand names, including Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West, each targeting specific demographics and geographic regions. This multi-brand strategy enables PulteGroup to maintain a strong presence in the US homebuilding market, with a wide range of home designs and price points to suit different customer segments. Additionally, the company provides financing options to homebuyers through mortgage loan origination, further streamlining the home purchasing process.
As a comprehensive homebuilding solutions provider, PulteGroup also offers ancillary services, such as title insurance policies, examination, and closing services, to facilitate a seamless transaction experience for its customers. With a history dating back to 1950, the company has established itself as a reputable player in the US homebuilding industry, with a strong track record of delivering high-quality homes and exceptional customer service. Headquartered in Atlanta, Georgia, PulteGroup, Inc. is a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol PHM, with its common stock classified under the GICS Sub Industry: Homebuilding.
Additional Sources for PHM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PHM Stock Overview
Market Cap in USD | 22,666m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 1985-07-01 |
PHM Stock Ratings
Growth 5y | 83.5% |
Fundamental | 63.6% |
Dividend | 53.4% |
Rel. Strength Industry | -34.1 |
Analysts | 3.82/5 |
Fair Price Momentum | 105.33 USD |
Fair Price DCF | 128.42 USD |
PHM Dividends
Dividend Yield 12m | 0.55% |
Yield on Cost 5y | 1.63% |
Annual Growth 5y | 7.99% |
Payout Consistency | 83.0% |
PHM Growth Ratios
Growth Correlation 3m | -85% |
Growth Correlation 12m | 77.2% |
Growth Correlation 5y | 82% |
CAGR 5y | 24.32% |
CAGR/Mean DD 5y | 1.74 |
Sharpe Ratio 12m | 0.22 |
Alpha | -34.05 |
Beta | 1.63 |
Volatility | 35.89% |
Current Volume | 990.6k |
Average Volume 20d | 1996.7k |
As of December 30, 2024, the stock is trading at USD 109.52 with a total of 990,600 shares traded.
Over the past week, the price has changed by -0.55%, over one month by -18.88%, over three months by -23.55% and over the past year by +6.83%.
Yes, based on ValueRay Fundamental Analyses, PulteGroup (NYSE:PHM) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 63.56 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHM as of December 2024 is 105.33. This means that PHM is currently overvalued and has a potential downside of -3.83%.
PulteGroup has received a consensus analysts rating of 3.82. Therefor, it is recommend to buy PHM.
- Strong Buy: 5
- Buy: 4
- Hold: 8
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PHM PulteGroup will be worth about 118.7 in December 2025. The stock is currently trading at 109.52. This means that the stock has a potential upside of +8.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 147.5 | 34.7% |
Analysts Target Price | 95.5 | -12.8% |
ValueRay Target Price | 118.7 | 8.4% |